AMOXICILLIN capsule

Страна: США

мова: англійська

Джерело: NLM (National Library of Medicine)

Активний інгредієнт:

AMOXICILLIN (UNII: 804826J2HU) (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)

Доступна з:

H.J. Harkins Company, Inc.

ІПН (Міжнародна Ім'я):

AMOXICILLIN

Склад:

AMOXICILLIN ANHYDROUS 250 mg

Адміністрація маршрут:

ORAL

Тип рецепту:

PRESCRIPTION DRUG

Терапевтичні свідчення:

1.1 Infections of the Ear, Nose, and Throat Amoxicillin capsules are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus species. (α- and β-hemolytic isolates only),Streptococcus pneumoniae, Staphylococcus spp., or Haemophilus influenzae. 1.2 Infections of the Genitourinary Tract Amoxicillin capsules are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Escherichia coli, Proteus mirabilis, or Enterococcus faecalis. 1.3 Infections of the Skin and Skin Structure Amoxicillin capsules are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus spp. (α- and β-hemolytic isolates only), Staphylococcusspp., or E. coli. 1.4 Infections of the Lower Respiratory Tract Amoxicillin capsules are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus spp. (α- and β-hemolytic isolates only), S. pneu

Статус Авторизація:

Abbreviated New Drug Application

Характеристики продукта

AMOXICILLIN- AMOXICILLIN CAPSULE
H.J. HARKINS COMPANY, INC.
----------
0011-0020
1.1 Infections of the Ear, Nose, and Throat
Amoxicillin capsules are indicated in the treatment of infections due
to susceptible (ONLY β-
lactamase–negative) isolates of Streptococcus species. (α- and
β-hemolytic isolates
only),Streptococcus pneumoniae, Staphylococcus spp., or Haemophilus
influenzae.
1.2 Infections of the Genitourinary Tract
Amoxicillin capsules are indicated in the treatment of infections due
to susceptible (ONLY β-
lactamase–negative) isolates of Escherichia coli, Proteus mirabilis,
or Enterococcus faecalis.
1.3 Infections of the Skin and Skin Structure
Amoxicillin capsules are indicated in the treatment of infections due
to susceptible (ONLY β-
lactamase–negative) isolates of Streptococcus spp. (α- and
β-hemolytic isolates only),
Staphylococcusspp., or E. coli.
1.4 Infections of the Lower Respiratory Tract
Amoxicillin capsules are indicated in the treatment of infections due
to susceptible (ONLY β-
lactamase–negative) isolates of Streptococcus spp. (α- and
β-hemolytic isolates only), S. pneumoniae,
Staphylococcus spp., or H. influenzae.
1.5 Helicobacter pylori Infection
Triple therapy for Helicobacter pylori with clarithromycin and
lansoprazole:
Amoxicillin capsules in combination with clarithromycin plus
lansoprazole as triple therapy, is
indicated for the treatment of patients with H. pylori infection and
duodenal ulcer disease (active or 1-
year history of a duodenal ulcer) to eradicate H. pylori. Eradication
of H. pylori has been shown to
reduce the risk of duodenal ulcer recurrence.
Dual therapy for H. pylori with lansoprazole: Amoxicillin capsules, in
combination with lansoprazole
delayed-release capsules as dual therapy, is indicated for the
treatment of patients with H.
pyloriinfection and duodenal ulcer disease (active or 1-year history
of a duodenal ulcer) who are either
allergic or intolerant to clarithromycin or in whom resistance to
clarithromycin is known or suspected.
(See the clar